Bevacizumab in the Treatment of Refractory Brain Edema in High-grade Glioma
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY(2024)
摘要
We report the case of a 14-year-old boy with a steroid-dependent refractory tumor whose longstanding dexamethasone treatment was successfully discontinued after a course of bevacizumab. The use of bevacizumab despite the absence of clear evidence of radionecrosis allowed a significant decrease in the amount of the brain edema.
更多查看译文
关键词
vasogenic brain edema,bevacizumab,dexamethasone,gliomas,oncology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要